Modulation of telomere shelterin by TFR1 and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer

Lung Cancer

Volumn 58, Issue 3, 2007, Pages 310-316

  Hsu, Chung Ping ^a,b   Ko, Jiunn Liang ^c   Shai, Sen Ei ^a   Lee, Li Wen ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Lung cancer; Telomerase; Telomere; TRF1; TRF2

Indexed keywords

CELL PROTEIN; PROTEIN SHELTERIN; PROTEIN SUBUNIT; PROTEIN TFR1; PROTEIN TFR2; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RESTRICTION FRAGMENT; TELOMERE;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; CARCINOMA, NON-SMALL-CELL LUNG; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROTEIN BINDING; RECEPTORS, TRANSFERRIN; TELOMERASE; TELOMERE; TELOMERE-BINDING PROTEINS; TELOMERIC REPEAT BINDING PROTEIN 2;

EID: 35748959667     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.06.019     Document Type: Article

References (31)

1. Allshire R.C., Dempster M., and Hastie N.D. Human telomeres contain at least three types of G-rich repeat distributed non-randomly. Nucleic Acids Res 17 (1989) 4611-4627
2. Moyzis R.K., Buckingham J.M., Cram L.S., Dani M., Deaven L.L., Jones M.D., et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 85 (1988) 6622-6626
3. Cross S.H., Allshire R.C., McKay S.J., McGill N.I., and Cooke H.J. Cloning of human telomeres by complementation in yeast. Nature 338 (1989) 771-774
4. Vaziri H., Schachter F., Uchida I., Wei L., Zhu X., Effros R., et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 52 (1993) 661-667
5. Blackburn E.H. Structure and function of telomeres. Nature 350 (1991) 569-573
6. Buchkovich K.J., and Greider C.W. Telomerase regulation during entry into the cell cycle in normal human T cells. Mol Biol Cell 7 (1996) 1443-1454
7. Harley C.B. Telomere loss: mitotic clock or genetic time bomb?. Mutat Res 256 (1991) 271-282
8. de Lange T. Protection of mammalian telomeres. Oncogene 21 (2002) 532-540
9. Stansel R.M., de Lange T., and Griffith J.D. T-loop assembly in vitro involves binding of TRF2 near the 3′ telomeric overhang. EMBO J 20 (2001) 5532-5540
10. Griffith J.D., Comeau L., Rosenfield S., Stansel R.M., Bianchi A., Moss H., et al. Mammalian telomeres end in a large duplex loop. Cell 97 (1999) 503-514
11. Liu D., O'Cononor M.S., Qin J., and Songyang Z. Telomere, a mammalian telomere-associated complex formed by multiple telomeric proteins. J Biol Chem 279 (2004) 51338-51342
12. Liu D., Safari A., O'Connor M.S., Chan D.W., Laegeler A., Qin J., et al. PTOP interacts with POT1 and regulates its localization to telomeres. Nat Cell Biol 424 (2004) 1013-1018
13. van Steenselvan B., and de Lange T. Control of telomere length by the human telomeric protein TRF1. Nature 385 (1997) 740-743
14. van Steenselvan B., Smogorzewska A., and de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell 92 (1998) 401-413
15. Smith S., Giriat I., Schmitt A., and de Lange T. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 282 (1998) 1484-1487
16. Hsu C.P., Miaw J., Hsia J.Y., Shai S.E., and Chen C.Y. Concordant expression of the telomerase-associated genes in non-small cell lung cancer. Eur J Surg Oncol 29 (2003) 594-599
17. Wu T.C., Lin P., Hsu C.P., Huang Y.J., Chen C.Y., Chung W.C., et al. Loss of telomerase activity may be a potential favorable prognostic marker in lung carcinomas. Lung Cancer 41 (2003) 163-169
18. Hsu C.P., Miaw J., Shai S.E., and Chen C.Y. Correlation between telomerase expression and terminal restriction fragment length ratio in non-small cell lung cancer-an adjusted measurement and its clinical significance. Eur J Cardiothorac Surg 26 (2004) 425-431
19. In: Greene F.L., Page D.L., Fleming I.D., Fritz A.G., Balch C.M., Haller D.G., and Morrow M. (Eds). AJCC cancer staging handbook. 6th ed. (2002), Springer-Verlag Inc., New York 191-203
20. Wright W.E., Shay J.W., and Piatyszek M.A. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 23 (1995) 3794-3795
21. Counter C.M., Avilion A.A., LeFeuvre C.E., Stewart N.G., Greider C.W., Harley C.B., et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11 (1992) 1921-1929
22. de Lange T., Shiue L., Myers R.M., Cox D.R., Naylor S.L., Killery A.M., et al. Structure and variability of human chromosome ends. Mol Cell Biol 10 (1990) 518-527
23. Smogorzewska A., and de Lange T. Regulation of telomerase by telomeric proteins. Annu Rev Biochem 73 (2004) 177-208
24. Hanaoka S., Nagadoi A., and Nishimura Y. Comparison between TRF2 and TRF1 of their telomeric DNA-bound structures and DNA-binding activities. Protein Sci 14 (2005) 119-130
25. Smith S., and de Lange T. Cell cycle dependent localization of the telomeric PARP, tankyrase, to nuclear pore complexes and centrosomes. J Cell Sci 112 (1999) 3649-3656
26. Ye J.R., and de Lange T. TIN2 is a tankyrase 1 PARP modulator in the TRF1 telomer length control complex. Nat Genet 36 (2004) 618-623
27. Houghtaling B.R., Cuttonaro L., Chang W., and Smith S. A dynamic molecular link between the telomere length regulator TRF1 and the chromosome end protector TRF2. Curr Biol 14 (2004) 1621-1631
28. Yamada M., Tsuji N., Nakamura M., Moriai R., Kobayashi D., Yagihashi A., et al. Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancers. Anticancer Res 22 (2002) 3303-3307
29. Oh B.K., Kim Y.J., Park C., and Park Y.N. Up-regulation of telomere-binding proteins, TRF1, TRF2, and TIN2 is related to telomere shortening during human multistep hepatocarcinogenesis. Am J Pathol 166 (2005) 73-80
30. Lin X., Gu J., Lu C., Spitz M.R., and Wu X. Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer. Clin Cancer Res 12 (2006) 5720-5725
31. Karlseder J., Smogorzewska A., and de Lange T. Senescence induced by altered telomere state, not telomere loss. Science 295 (2002) 2446-2449